| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.60B | 12.04B | 12.52B | 11.87B | 10.70B | 9.89B |
| Gross Profit | 1.62B | 1.46B | 2.33B | 1.96B | 1.20B | 1.15B |
| EBITDA | 1.29B | 1.11B | 1.73B | 1.36B | 708.48M | 524.75M |
| Net Income | 1.81B | 2.04B | 572.70M | 416.13M | -192.95M | -94.19M |
Balance Sheet | ||||||
| Total Assets | 30.90B | 31.26B | 29.12B | 28.67B | 28.91B | 26.99B |
| Cash, Cash Equivalents and Short-Term Investments | 7.23B | 7.89B | 7.49B | 8.97B | 9.72B | 8.68B |
| Total Debt | 2.92B | 3.10B | 3.30B | 3.04B | 3.65B | 2.12B |
| Total Liabilities | 6.69B | 6.47B | 6.52B | 7.02B | 7.84B | 5.72B |
| Stockholders Equity | 23.15B | 23.76B | 21.60B | 20.73B | 20.18B | 20.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.44B | -2.80B | -1.02B | -1.21B | -2.61B |
| Operating Cash Flow | 0.00 | 1.21B | 618.20M | 1.50B | 1.27B | 231.73M |
| Investing Cash Flow | 0.00 | 636.60M | -639.32M | -2.73B | -348.57M | 1.40B |
| Financing Cash Flow | 0.00 | -432.55M | 120.03M | -31.32M | 1.42B | -238.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥5.77B | 5.29 | ― | 3.02% | 7.54% | 44.72% | |
72 Outperform | ¥10.86B | 5.41 | ― | 4.99% | 6.11% | 207.55% | |
71 Outperform | ¥24.04B | 3.25 | ― | 1.29% | 4.21% | 35.32% | |
65 Neutral | ¥11.47B | 10.98 | ― | 1.87% | -0.35% | 11.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥3.72B | 8.39 | ― | 2.93% | 0.09% | -44.81% | |
50 Neutral | ¥6.64B | 19.26 | ― | 0.30% | -0.38% | 413.00% |